Every open market buy and sale of CRISPR Therapeutics AG stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $17.9M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when CRSP insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an CRSP officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every CRSP insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Samarth KulkarniCEO | Sale | 47,837 | $49.78 | $2.4M | 311,899 | Oct 20Form 4 |
| Oct 14, 2026 | Simeon GeorgeDirector | Sale plan | 14,514 | $49.63 | $720K | 15,486 | Oct 16Form 4 |
| Oct 14, 2026 | Samarth KulkarniCEO | Sale | 4,098 | $49.26 | $202K | 259,736 | Oct 15Form 4 |
| Oct 14, 2026 | James R. KasingerGeneral Counsel and Secretary | Sale | 1,040 | $49.26 | $51K | 95,857 | Oct 15Form 4 |
| Oct 6, 2026 | James R. KasingerGeneral Counsel and Secretary | Sale plan | 1,990 | $60.04 | $119K | 94,784 | Oct 8Form 4 |
| Sep 22, 2026 | James R. KasingerGeneral Counsel and Secretary | Sale plan | 10,400 | $60.24 | $626K | 94,784 | Sep 24Form 4 |
| Sep 17, 2026 | Ali BehbahaniDirector | Sale | 13,679 | $57.09 | $781K | 16,637 | Sep 21Form 4 |
| May 29, 2026 | Naimish PatelChief Medical Officer | Sale | 3,786 | $55.62 | $211K | 19,357 | Jun 1Form 4 |
| Mar 23, 2026 | Raju PrasadCFO | Sale | 3,708 | $46.78 | $173K | 15,565 | Mar 24Form 4 |
| Mar 23, 2026 | Samarth KulkarniCEO | Sale | 10,020 | $46.78 | $469K | 255,501 | Mar 24Form 4 |
| Mar 23, 2026 | James R. KasingerGeneral Counsel and Secretary | Sale | 3,182 | $46.78 | $149K | 94,308 | Mar 24Form 4 |
| Mar 16, 2026 | Samarth KulkarniCEO | Sale | 10,349 | $48.26 | $499K | 245,834 | Mar 17Form 4 |
| Mar 16, 2026 | James R. KasingerGeneral Counsel and Secretary | Sale | 3,450 | $48.26 | $166K | 91,240 | Mar 17Form 4 |
| Mar 16, 2026 | Raju PrasadCFO | Sale | 9,869 | $48.26 | $476K | 13,773 | Mar 17Form 4 |
| Mar 16, 2026 | Naimish PatelChief Medical Officer | Sale | 3,150 | $48.26 | $152K | 13,143 | Mar 17Form 4 |
CRSP insider trading FAQ
Are CRSP insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of CRSP on the open market in 0 trades, and 6 sold $17.9M in 23 trades, 62% of that under pre-arranged trading plans.
When did an CRSP insider last buy shares?
Douglas A Treco (Director) bought 20,000 shares for $1.1M on Aug 6, 2025, reported on Aug 8, 2025.
When did an CRSP insider last sell shares?
Samarth Kulkarni (CEO) sold 47,837 shares for $2.4M on Oct 19, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
